Elixinol Wellness (AU:EXL) has released an update.
Elixinol Wellness announced a significant change in the stock holdings of Director David Fenlon, who acquired 938,087 fully paid ordinary shares, increasing his stake to over 1.5 million shares. This acquisition was made through Director Fee Rights in lieu of cash, reflecting a strategic move by the company to align management interests with shareholders.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.